KalVista Pharma Reports Q3 Earnings Results: What Investors Need to Know
KalVista Pharma (NASDAQ: KALV) recently reported its Q3 earnings results, and investors are taking note of the outcome. The company’s earnings announcement, which took place on Monday, March 11, 2024 at 06:30 AM, revealed some interesting figures that investors should be aware of.
Earnings & Revenue
One of the key highlights from the earnings report is that KalVista Pharma missed estimated earnings by -9.0%, reporting an EPS of $-0.84 versus an estimate of $-0.77. Additionally, revenue was down $0 from the same period last year. These figures indicate a mixed performance for the company in the latest quarter.
Past Earnings Performance
Looking back at the company’s past earnings performance, last quarter KalVista Pharma missed on EPS by $0.01, which resulted in a 9.0% drop in the share price the next day. This trend suggests that investors closely monitor the company’s earnings reports and react accordingly to any deviations from expectations.
Investor Insights
For investors interested in listening to the earnings announcement themselves, a link is provided in the article for direct access. Additionally, for those looking to track all earnings releases for KalVista Pharma, a link to their earnings calendar is also included for easy reference.
Conclusion
Overall, KalVista Pharma’s Q3 earnings results provide valuable insights for investors looking to understand the company’s financial performance and trajectory. With missed earnings and stagnant revenue, investors may want to closely monitor the company’s future developments and earnings reports to make informed investment decisions.
This article was generated by Benzinga’s automated content engine and reviewed by an editor. For more information on earnings announcements and other financial news, visit Benzinga.com.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
